Topotarget Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$108M
Topotarget General Information
Description
Producer of biopharmaceutical products. The company engages in clinical development and registration of oncology products. It primarily develops drugs for the treatment of hematological malignancies, solid tumors and cancer therapies.
Contact Information
Website
www.topotarget.comCorporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
Corporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
Topotarget Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 05-Aug-2014 | $108M | Completed | Profitable | ||
| 2. Early Stage VC | 27-Jun-2007 | Completed | Startup | |||
| 1. Early Stage VC | 01-Dec-2006 | $24.4M | $24.4M | Completed | Startup |
Topotarget Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 156,116 | $3.03 | $3.03 | 1x | $3.03 | 0.25% | ||
| Ordinary Shares | 577,700 | $1.5 | $1.5 | 1x | $1.5 | 0.94% |
Topotarget Signals
Topotarget Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Banexi Ventures Partners | Venture Capital | Minority | ||
| HealthCap | Venture Capital | Minority |
Topotarget Acquisitions (2)
Topotarget’s most recent deal was a Merger/Acquisition with Apoxis for . The deal was made on 27-Jun-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Apoxis | 27-Jun-2007 | Merger/Acquisition | Drug Discovery | ||
| Prolifix | 04-Jun-2002 | Merger/Acquisition | Drug Discovery |
Topotarget FAQs
-
When was Topotarget founded?
Topotarget was founded in 2000.
-
Where is Topotarget headquartered?
Topotarget is headquartered in Copenhagen, Denmark.
-
What is the size of Topotarget?
Topotarget has 13 total employees.
-
What industry is Topotarget in?
Topotarget’s primary industry is Drug Discovery.
-
Is Topotarget a private or public company?
Topotarget is a Private company.
-
What is the current valuation of Topotarget?
The current valuation of Topotarget is .
-
What is Topotarget’s current revenue?
The current revenue for Topotarget is .
-
How much funding has Topotarget raised over time?
Topotarget has raised $109M.
-
Who are Topotarget’s investors?
Banexi Ventures Partners and HealthCap have invested in Topotarget.
-
When was Topotarget acquired?
Topotarget was acquired on 05-Aug-2014.
-
Who acquired Topotarget?
Topotarget was acquired by Valerio Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process